AbbVie Inc (ABBV)
171.73
+3.97
(+2.37%)
USD |
NYSE |
Nov 21, 16:00
171.97
+0.24
(+0.14%)
After-Hours: 20:00
AbbVie Revenue (Quarterly): 14.46B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.46B |
| June 30, 2024 | 14.46B |
| March 31, 2024 | 12.31B |
| December 31, 2023 | 14.30B |
| September 30, 2023 | 13.93B |
| June 30, 2023 | 13.86B |
| March 31, 2023 | 12.22B |
| December 31, 2022 | 15.12B |
| September 30, 2022 | 14.81B |
| June 30, 2022 | 14.58B |
| March 31, 2022 | 13.54B |
| December 31, 2021 | 14.89B |
| September 30, 2021 | 14.34B |
| June 30, 2021 | 13.96B |
| March 31, 2021 | 13.01B |
| December 31, 2020 | 13.86B |
| September 30, 2020 | 12.90B |
| June 30, 2020 | 10.42B |
| March 31, 2020 | 8.619B |
| December 31, 2019 | 8.704B |
| September 30, 2019 | 8.479B |
| June 30, 2019 | 8.255B |
| March 31, 2019 | 7.828B |
| December 31, 2018 | 8.305B |
| September 30, 2018 | 8.236B |
| Date | Value |
|---|---|
| June 30, 2018 | 8.278B |
| March 31, 2018 | 7.934B |
| December 31, 2017 | 7.739B |
| September 30, 2017 | 6.995B |
| June 30, 2017 | 6.944B |
| March 31, 2017 | 6.538B |
| December 31, 2016 | 6.796B |
| September 30, 2016 | 6.432B |
| June 30, 2016 | 6.452B |
| March 31, 2016 | 5.958B |
| December 31, 2015 | 6.40B |
| September 30, 2015 | 5.944B |
| June 30, 2015 | 5.475B |
| March 31, 2015 | 5.04B |
| December 31, 2014 | 5.452B |
| September 30, 2014 | 5.019B |
| June 30, 2014 | 4.926B |
| March 31, 2014 | 4.563B |
| December 31, 2013 | 5.111B |
| September 30, 2013 | 4.658B |
| June 30, 2013 | 4.692B |
| March 31, 2013 | 4.329B |
| December 31, 2012 | 5.206B |
| September 30, 2012 | 4.508B |
| June 30, 2012 | 4.493B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.619B
Minimum
Mar 2020
15.12B
Maximum
Dec 2022
13.22B
Average
13.90B
Median
Revenue (Quarterly) Benchmarks
| Amgen Inc | 8.503B |
| Johnson & Johnson | 22.47B |
| Eli Lilly and Co | 11.44B |
| Merck & Co Inc | 16.66B |
| Pfizer Inc | 17.70B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.561B |
| Total Expenses (Quarterly) | 10.55B |
| EPS Diluted (Quarterly) | 0.88 |
| Enterprise Value | 367.30B |
| Gross Profit Margin (Quarterly) | 70.87% |
| Profit Margin (Quarterly) | 10.80% |
| Earnings Yield | 1.68% |
| Operating Earnings Yield | 4.77% |
| Normalized Earnings Yield | 1.837 |